Thaddeus J. Wadas, Ph.D.
Assistant Professor, Radiology
cancer/oncogenesis, drugs/therapeutic agents pharm, men?s health issues, nuclear medicine, radiology imaging/nuclear medi
Academic: 336-716-5696 | Department: 336-716-5696
N Tinianow J, Pandya DN, Pailloux SL, Ogasawara A, Vanderbilt AN, Gill HS, Williams SP, Wadas TJ, Magda D, Marik J. Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) based macrocyclic chelator for (89)Zr(4+) and its use for immunoPET imaging of HER2 positive model of ovarian carcinoma in mice. Theranostics. 2016;6(4):511-521.
Pandya DN, Hantgan R, Budzevich MM, Kock ND, Morse DL, Batista I, Mintz A, Li KC, Wadas TJ. Preliminary therapy evaluation of (225)Ac-DOTA-c(RGDyK) demonstrates that cerenkov radiation derived from (225)Ac daughter decay can be detected by optical imaging for in vivo tumor visualization. Theranostics. 2016;6(5):698-709.
Pandya DN, Pailloux S, Tatum D, Magda D, Wadas TJ. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89. Chem Commun (Camb). 2015;51(12):2301-2303.
Sattiraju A, Xiong XB, Pandya D, Sun Y, Jung Y, Wadas T, Li K, Mintz A. Permeabilizing the blood-brain-barrier with alpha-particle therapy [abstract]. J Nucl Med. 2015;56(3 Suppl 3):1230.
Wadas TJ, Pandya DN, Solingapuram Sai KK, Mintz A. Molecular targeted alpha-particle therapy for oncologic applications. AJR Am J Roentgenol. 2014;203(2):253-260.
Shokeen M, Wadas TJ. The development of copper radiopharmaceuticals for imaging and therapy. Med Chem. 2011;7(5):413-429.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.